SLC26A11 and breast carcinoma: Despite silico-derived data being obtained from a small number of patients, we were able to identify ALDH1A3, MED20, PABPC4, SLC26A11 and SCP2 as deregulated genes in diabetic breast cancer patients, which coincided with our microarray data.